| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Anesthesiology, University of Ulm, Ulm, Germany
(V.W., K.H.L., S.A., A.W.P., H.U.S.); the Department of Anaesthesia and
Intensive Care Medicine, Leopold Franzens University of Innsbruck, Austria
(V.W., K.H.L., S.A., H.U.S.); and the Department of Anesthesiology,
Knappschaft Hospital, Ruhr University, Bochum, Germany (A.W.P.).
Correspondence to Dr Volker Wenzel, The Leopold Franzens University of Innsbruck, Department of Anaesthesia and Intensive Care Medicine, Anichstrasse 35, 6020 Innsbruck, Austria. E-mail Volker.Wenzel{at}uibk.ac.at
Background and PurposeIt is unknown
whether a combination of vasopressin and epinephrine may be
superior to vasopressin alone by targeting both
nonadrenergic and adrenergic receptors.
MethodsAfter 15 minutes of cardiac arrest (13 minutes of
ventricular fibrillation and 2 minutes of pulseless
electrical activity) and 3 minutes of chest compressions, 16 animals
were randomly treated with either 0.8 U/kg vasopressin (n=8) or 0.8
U/kg vasopressin combined with 200 µg/kg epinephrine
(n=8).
ResultsComparison of vasopressin with vasopressin and
epinephrine at 90 seconds and 5 minutes after drug
administration resulted in comparable mean (±SEM) coronary
perfusion pressure (54±3 versus 57±5 and 36±4 versus 35±4
mm Hg, respectively), cerebral perfusion pressure (59±6 versus 65±8
and 40±6 versus 39±6 mm Hg, respectively), and median (25th to
75th percentiles) left ventricular myocardial blood flow
[116 (81 to 143) versus 108 (97 to 125) and 44 (35 to 81) versus 62
(42 to 74) mL · min-1 · 100
g-1, respectively], but significantly increased
(P<0.05) total cerebral blood flow [81 (77 to 95)
versus 39 (34 to 58) and 50 (43 to 52) versus 28 (16 to 35) mL ·
min-1 · 100 g-1, respectively].
Return of spontaneous circulation rates in both groups were comparable
(vasopressin, 7 of 8; vasopressin and epinephrine, 6 of 8).
ConclusionsComparison of vasopressin with vasopressin and
epinephrine resulted in comparable left ventricular
myocardial blood flow but significantly increased cerebral perfusion.
Department
of Anesthesiology/Critical Care Medicine The Johns
Hopkins University Baltimore, Maryland
© 1998 American Heart Association, Inc.
Original Contributions
Vasopressin Combined With Epinephrine Decreases Cerebral Perfusion Compared With Vasopressin Alone During Cardiopulmonary Resuscitation in Pigs
Editorial Comment
This article has been cited by other articles:
![]() |
V. D. Mayr, V. Wenzel, W. G. Voelckel, A. C. Krismer, T. Mueller, K. G. Lurie, and K. H. Lindner Developing a Vasopressor Combination in a Pig Model of Adult Asphyxial Cardiac Arrest Circulation, October 2, 2001; 104(14): 1651 - 1656. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. V. DiGregorio Pharmacotherapeutic Advances in Cardiac Resuscitation: A Review of the Advanced Cardiac Life Support (ACLS) 2000 Guidelines and Their Impact on Pharmacy Practice Journal of Pharmacy Practice, February 1, 2001; 14(1): 41 - 53. [Abstract] [PDF] |
||||
![]() |
U. Achleitner, V. Wenzel, H.-U. Strohmenger, A. C. Krismer, K. G. Lurie, K. H. Lindner, and A. Amann The Effects of Repeated Doses of Vasopressin or Epinephrine on Ventricular Fibrillation in a Porcine Model of Prolonged Cardiopulmonary Resuscitation Anesth. Analg., May 1, 2000; 90(5): 1067 - 1075. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Ewy and J. P. Ornato Emergency cardiac care: introduction J. Am. Coll. Cardiol., March 15, 2000; 35(4): 825 - 880. [Full Text] [PDF] |
||||
![]() |
V. Wenzel, K. H. Lindner, A. C. Krismer, W. G. Voelckel, M. F. Schocke, W. Hund, M. Witkiewicz, E. A. Miller, G.u. Klima, J.o. Wissel, et al. Survival with full neurologic recovery and no cerebral pathology after prolonged cardiopulmonary resuscitation with vasopressin in pigs J. Am. Coll. Cardiol., February 1, 2000; 35(2): 527 - 533. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |